PTHvsGNMXETF Comparison
VS
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PTH is more expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of PTH and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PTH vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH GNMX | +5.19%+1.85% | +12.36%n/a | +17.82%n/a | +58.30%n/a | +56.89%n/a | +7.61%n/a |
| Flows | PTH GNMX | +$102M- | +$94M- | +$88M- | +$92M- | +$25M- | -$192M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH GNMX | +29.53%n/a | +24.63%n/a | +25.60%n/a | +25.58%n/a |
| Max drawdown | PTH GNMX | -8.31%n/a | -11.91%n/a | -27.71%n/a | -50.10%n/a |
| Max drawdown duration | PTH GNMX | 41dn/a | 140dn/a | 353dn/a | 1756dn/a |
Trading data
PTH | GNMX | |
Last sale 7/24/2026 at 1:30 PM | $58.57 | |
| Previous close 07/23/2026 | $59.39 | |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexPTH | GNMX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
PTH | GNMX | |
|---|---|---|
| Last price | $58.57 | – |
| 1D performance | -1.38% | – |
| AuM | $231.95 M | $1.64 M |
| E/R | 0.72% | 0.35% |
Characteristics
PTH | GNMX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Corgi Funds |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | - |
| N° of holdings | 57 | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
PTH
USA
92.25%
Other
7.75%
GNMX
USA
89.37%
Other
10.63%
Sectors
PTH
Healthcare
100%
Other
0%
GNMX
Healthcare
98.21%
Other
1.79%
Advertisement
Diversification
PTH
Total weight of top 15 holdings out of 15
43.88%
GNMX
Total weight of top 15 holdings out of 15
53.1%
Top 15 holdings
Data as of June 30, 2026
PTH
Roivant Sciences Ltd.
4.95%
Praxis Precision Medicines, Inc.
4.66%
Tango Therapeutics, Inc.
3.70%
SELLAS Life Sciences Group, Inc.
3.36%
United Therapeutics Corp.
2.91%
Tenet Healthcare Corp.
2.89%
Axsome Therapeutics, Inc.
2.74%
BrightSpring Health Services, Inc.
2.54%
Liquidia Corp.
2.52%
Moderna, Inc.
2.49%
Ionis Pharmaceuticals, Inc.
2.30%
Erasca, Inc.
2.29%
HCA Healthcare, Inc.
2.23%
Twist Bioscience Corp.
2.21%
Protagonist Therapeutics, Inc.
2.08%
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
Frequently asked questions about PTH and GNMX
Which ETF is bigger: PTH or GNMX?
As of July 24, 2026, PTH holds $231.95 M in assets under management (AUM), while GNMX manages $1.64 M.
What sectors do the PTH and GNMX ETFs invest in?
PTH leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the PTH ETF and GNMX ETF?
PTH top holdings include Roivant Sciences Ltd., Praxis Precision Medicines, Inc. and Tango Therapeutics, Inc.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc..
Which ETF is more diversified: PTH or GNMX?
PTH holds 57 securities with 43.88% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 53.1%.
Advertisement
Latest news about PTH & GNMX
Advertisement
